Grifols, S.A ROE 2012-2020 | GRFS

Current and historical return on equity (ROE) values for Grifols, S.A (GRFS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Grifols, S.A ROE for the three months ending June 30, 2020 was 10.83%.
Grifols, S.A ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.77B $7.95B 13.87%
2019-06-30 $0.70B $5.49B 15.44%
2018-06-30 $0.66B $4.74B 15.65%
2017-06-30 $0.61B $3.94B 15.15%
2017-03-31 $0.61B $4.07B 15.21%
2016-12-31 $0.60B $4.13B 15.50%
2016-09-30 $0.60B $3.94B 15.81%
2016-06-30 $0.60B $3.86B 16.17%
2016-03-31 $0.59B $3.64B 16.40%
2015-12-31 $0.59B $3.67B 16.71%
2015-09-30 $0.60B $3.56B 17.00%
2015-06-30 $0.59B $3.40B 17.10%
2015-03-31 $0.58B $3.54B 17.28%
2014-12-31 $0.61B $3.54B 18.64%
2014-09-30 $0.56B $3.37B 18.29%
2014-06-30 $0.52B $3.07B 18.15%
2014-03-31 $0.51B $3.05B 18.37%
2013-12-31 $0.46B $2.80B 17.28%
2013-09-30 $0.43B $2.61B 16.82%
2013-06-30 $0.40B $2.54B 16.01%
2013-03-31 $0.36B $2.59B 14.82%
2012-12-31 $0.33B $2.42B 14.09%
2012-09-30 $0.26B $2.32B 11.34%
2012-06-30 $0.22B $2.36B 9.44%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $12.823B $5.711B
Grifols, S.A., operates in the pharmaceutical-hospital sector engaged in the research, development and retailing of plasma derivates, products for intravenous therapy, clinical nutrition, diagnostic and hospital logistics systems. The Company operates its business through three divisions: Bioscience Division, Diagnostic Division and Hospital Division. The Bioscience division is engaged in the research, development, production and commercialization of plasma derivates. Diagnostic Division focuses on researching, developing, manufacturing and marketing diagnostics products for laboratory analysis, including products for Hospital Blood Banks and Transfusion Centers. Hospital Division provides non-biological products used in hospital pharmacies, surgery, nutritional support, fluid therapy and for other therapeutic uses. Grifols, S.A. is based in Barcelona, Spain.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $74.908B 42.51
Takeda Pharmaceutical (TAK) Japan $58.105B 10.13
Astellas Pharma (ALPMY) Japan $29.990B 15.20
UCB SA (UCBJF) Belgium $24.702B 0.00
Eisai (ESALY) Japan $24.615B 20.80
Merck (MKGAF) Germany $17.041B 22.35
Catalent (CTLT) United States $13.882B 53.67
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Neurocrine Biosciences (NBIX) United States $11.091B 42.94
Ono Pharmaceutical (OPHLF) Japan $9.254B 16.36
Ionis Pharmaceuticals (IONS) United States $8.008B 50.87
Orion OYJ (ORINY) Finland $7.077B 24.56
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.906B 0.00
STADA ARZNEIMI (STDAF) Germany $6.858B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.779B 11.22
United Therapeutics (UTHR) United States $5.022B 11.61
Arrowhead Pharmaceuticals (ARWR) United States $4.433B 0.00
Hypermarcas (HYPMY) Brazil $4.183B 15.39
Evotec AG (EVTCY) Germany $4.165B 112.25
Nektar Therapeutics (NKTR) United States $3.871B 0.00
FibroGen (FGEN) United States $3.800B 0.00
ChemoCentryx (CCXI) United States $3.424B 0.00
PTC Therapeutics (PTCT) United States $3.207B 0.00
Sage Therapeutics (SAGE) United States $2.632B 0.00
Cronos Group (CRON) Canada $2.442B 69.80
Taro Pharmaceutical Industries (TARO) Israel $2.400B 11.61
Pacira BioSciences (PCRX) United States $2.363B 48.36
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.829B 0.00
Xencor (XNCR) United States $1.757B 0.00
USANA Health Sciences (USNA) United States $1.750B 16.48
Corcept Therapeutics (CORT) United States $1.659B 15.28
Indivior (INVVY) United States $1.649B 20.47
Heron Therapeutics (HRTX) United States $1.584B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.578B 17.00
Ironwood Pharmaceuticals (IRWD) United States $1.536B 11.76
Akebia Therapeutics (AKBA) United States $1.452B 0.00
Revolution Medicines (RVMD) United States $1.449B 0.00
Zogenix (ZGNX) United States $1.353B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.286B 0.00
Karyopharm Therapeutics (KPTI) United States $1.158B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.138B 0.00
Esperion Therapeutics (ESPR) United States $1.073B 0.00
VAXART, INC (VXRT) United States $1.054B 0.00
Tilray (TLRY) Canada $1.013B 0.00
Translate Bio (TBIO) United States $0.954B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.922B 575.88
Altimmune (ALT) United States $0.869B 0.00
Endo (ENDP) Ireland $0.829B 1.23
BioCryst Pharmaceuticals (BCRX) United States $0.743B 0.00
Vectura Group (VEGPF) United Kingdom $0.737B 0.00
ImmunoGen (IMGN) United States $0.697B 0.00
Trillium Therapeutics (TRIL) Canada $0.643B 0.00
Collegium Pharmaceutical (COLL) United States $0.594B 0.00
Radius Health (RDUS) United States $0.558B 0.00
TherapeuticsMD (TXMD) United States $0.557B 0.00
Aerie Pharmaceuticals (AERI) United States $0.555B 0.00
Siga Technologies (SIGA) United States $0.545B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.518B 0.00
Molecular Templates (MTEM) United States $0.516B 0.00
Ardelyx (ARDX) United States $0.510B 0.00
Innate Pharma SA (IPHYF) France $0.489B 0.00
Flexion Therapeutics (FLXN) United States $0.487B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.482B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.474B 18.49
DURECT (DRRX) United States $0.467B 0.00
Ocular Therapeutix (OCUL) United States $0.466B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.427B 10.32
Rigel Pharmaceuticals (RIGL) United States $0.426B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.419B 0.00
Organogenesis Holdings (ORGO) United States $0.406B 0.00
Calithera Biosciences (CALA) United States $0.358B 0.00
Harpoon Therapeutics (HARP) United States $0.318B 0.00
IMV INC (IMV) Canada $0.311B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.309B 0.00
PROFOUND MEDICL (PROF) Canada $0.298B 0.00
MEI Pharma (MEIP) United States $0.296B 0.00
Concert Pharmaceuticals (CNCE) United States $0.283B 0.00
OptiNose (OPTN) United States $0.283B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.272B 0.00
Redhill Biopharma (RDHL) Israel $0.265B 0.00
Lannett Co Inc (LCI) United States $0.253B 5.54
CASI Pharmaceuticals (CASI) United States $0.232B 0.00
Rafael Holdings (RFL) United States $0.230B 0.00
KalVista Pharmaceuticals (KALV) United States $0.201B 0.00
Aquestive Therapeutics (AQST) United States $0.199B 0.00
Nivalis Therapeutics (ALPN) United States $0.198B 0.00
Taiwan Liposome (TLC) Taiwan $0.195B 0.00
Nature's Sunshine Products (NATR) United States $0.192B 25.26
Onconova Therapeutics (ONTX) United States $0.187B 0.00
Heat Biologics (HTBX) United States $0.185B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.165B 0.00
Jounce Therapeutics (JNCE) United States $0.156B 3.72
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.141B 0.00
Xeris Pharmaceuticals (XERS) United States $0.127B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.118B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Otonomy (OTIC) United States $0.115B 0.00
MediWound (MDWD) Israel $0.112B 0.00
Champions Oncology (CSBR) United States $0.112B 0.00
CTI BioPharma (CTIC) United States $0.108B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.107B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.105B 0.00
Biomerica (BMRA) United States $0.104B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.102B 0.00
Recro Pharma (REPH) United States $0.100B 0.00
Hemispherx BioPharma (AIM) United States $0.096B 0.00
Lipocine (LPCN) United States $0.094B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.094B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.092B 0.00
Aclaris Therapeutics (ACRS) United States $0.090B 0.00
ElectroCore (ECOR) United States $0.086B 0.00
CV Sciences (CVSI) United States $0.079B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.075B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
PolarityTE (PTE) United States $0.063B 0.00
Sundial Growers (SNDL) Canada $0.061B 0.00
Infinity Pharmaceuticals (INFI) United States $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.051B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.64
Novan (NOVN) United States $0.051B 0.00
IsoRay (ISR) United States $0.046B 0.00
Forward Pharma (FWP) Denmark $0.046B 0.00
GTx (ONCT) United States $0.045B 0.00
Natural Alternatives (NAII) United States $0.045B 0.00
Jaguar Animal Health (JAGX) United States $0.043B 0.00
Mannatechorporated (MTEX) United States $0.042B 8.01
Entasis Therapeutics Holdings (ETTX) United States $0.042B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.039B 84.00
NovaBay Pharmaceuticals (NBY) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
Neos Therapeutics (NEOS) United States $0.036B 0.00
Can-Fite Biopharma (CANF) Israel $0.035B 0.00
India Globalization Capital (IGC) United States $0.028B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.028B 0.00
ProPhase Labs (PRPH) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
RXi Pharmaceuticals (PHIO) United States $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 33.57
Midatech Pharma (MTP) United Kingdom $0.014B 0.00
Shineco (TYHT) China $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.011B 0.00
Vical (BBI) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.008B 0.00
HANCOCK JAFFE (HJLI) United States $0.008B 0.00
Addex Therapeutics (ADXN) Switzerland $0.000B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00